This single-center, retrospective, cohort study to evaluate the safety and efficacy of Blinatumomab in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia

Trial Profile

This single-center, retrospective, cohort study to evaluate the safety and efficacy of Blinatumomab in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Jan 2016

At a glance

  • Drugs Blinatumomab (Primary)
  • Indications Acute lymphoblastic leukaemia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 23 Jan 2016 New trial record
    • 08 Dec 2015 Results of retrospective cohort analysis were presented at the 57th Annual Meeting and Exposition of the American Society of Hematology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top